AP NEWS
This content is a press release from our partner Business Wire. The AP newsroom and editorial departments were not involved in its creation.
PRESS RELEASE from provider: Business Wire
This content is a press release from our partner Business Wire. The AP newsroom and editorial departments were not involved in its creation.

Masimo to Present at Barclays Global Healthcare Conference

March 6, 2019

IRVINE, Calif.--(BUSINESS WIRE)--Mar 6, 2019--Masimo (NASDAQ: MASI) today announced that its management is scheduled to present at the Barclays Global Healthcare Conference at the Loews Miami Beach Hotel on Wednesday, March 13, 2019 at 4:50 p.m. Eastern Time. A live audiocast of the presentation will be available on the Masimo website at www.masimo.com. A replay of the audiocast will be available following the live presentation.

About Masimo

Masimo (NASDAQ: MASI) is a global leader in innovative noninvasive monitoring technologies. Our mission is to improve patient outcomes and reduce the cost of care by taking noninvasive monitoring to new sites and applications. In 1995, the company debuted Masimo SET ® Measure-through Motion and Low Perfusion ™ pulse oximetry, which has been shown in multiple studies to significantly reduce false alarms and accurately monitor for true alarms. Masimo SET ® is estimated to be used on more than 100 million patients in leading hospitals and other healthcare settings around the world. In 2005, Masimo introduced rainbow ® Pulse CO-Oximetry technology, allowing noninvasive and continuous monitoring of blood constituents that previously could only be measured invasively, including total hemoglobin (SpHb ® ), oxygen content (SpOC ™ ), carboxyhemoglobin (SpCO ® ), methemoglobin (SpMet ® ), and more recently, Pleth Variability Index (PVI ® ) and Oxygen Reserve Index (ORI ™ ), in addition to SpO2, pulse rate and perfusion index (PI). In 2014, Masimo introduced Root ®, an intuitive patient monitoring and connectivity platform with the Masimo Open Connect ™ (MOC-9 ™ ) interface. Masimo is also taking an active leadership role in mHealth with products such as the Radius-7 ™ wearable patient monitor and the MightySat ™ fingertip pulse oximeter. Additional information about Masimo and its products may be found at www.masimo.com.

Masimo, SET, Signal Extraction Technology, Improving Patient Outcome and Reducing Cost of Care... by Taking Noninvasive Monitoring to New Sites and Applications, rainbow, SpHb, SpOC, SpCO, SpMet, PVI and ORI are trademarks or registered trademarks of Masimo Corporation

View source version on businesswire.com:https://www.businesswire.com/news/home/20190306005052/en/

CONTACT: Investor Contact: Eli Kammerman

(949) 297-7077

ekammerman@masimo.comMedia Contact: Irene Paigah

(858) 859-7001

irenep@masimo.com

KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA FLORIDA

INDUSTRY KEYWORD: HEALTH MEDICAL DEVICES

SOURCE: Masimo

Copyright Business Wire 2019.

PUB: 03/06/2019 09:00 AM/DISC: 03/06/2019 09:01 AM

http://www.businesswire.com/news/home/20190306005052/en